Package Leaflet: Information for the User
Voltadol 140 mg medicated adhesive patch
diclofenac sodium
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
Voltadol is a medicine that relieves pain. It belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is used for the symptomatic local and short-term (up to 7 days) treatment of pain associated with sprains, strains, or bruises in the arms and legs as a result of blunt injuries in adolescents from 16 years of age and adults.
Do not use VOLTADOL
Warnings and precautions
Consult your doctor or pharmacist before starting to use this medicine
The side effects can be reduced by using the lowest effective dose for the shortest possible time.
Important precautions
After removing the medicated patch, avoid exposing the treated area to direct sunlight or radiation in a solarium to reduce the risk of sensitivity to light.
Do not use this medicine at the same time as any other medicine that contains diclofenac or other non-steroidal anti-inflammatory drugs, whether used externally or taken orally.
Children and adolescents
Diclofenac is contraindicated for use in children and adolescents under 16 years of age. There is not enough data on the efficacy and safety in the case of children and adolescents under 16 years of age (see section "Do not use VOLTADOL").
Other medicines and VOLTADOL
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicine.
As long as this medicine is used correctly, the body only absorbs a small amount of diclofenac, so it is unlikely that the interactions described for medicines that contain diclofenac and are taken orally will occur.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
In the last trimester of pregnancy, VOLTADOL should not be used because it cannot be ruled out that there is a higher risk of complications for the mother and child (see "Do not use VOLTADOL").
In the first and second trimester of pregnancy or if you wish to become pregnant, this medicine should only be used after consulting your doctor. If you need treatment during this period, you should take the minimum possible dose for the shortest possible time.
Oral formulations (e.g., tablets) of diclofenac may cause adverse reactions in the fetus. It is not known if this same risk applies to Voltadol when used on the skin.
Breastfeeding
Small amounts of diclofenac are excreted in breast milk.
Consult your doctor before starting to use this medicine during breastfeeding. In any case, if you are breastfeeding, VOLTADOL should not be applied directly to the breast area.
Driving and using machines
The influence of this medicine on the ability to drive and use machines is nil.
VOLTADOLcontains butylhydroxyanisole (E 320)
Butylhydroxyanisole may cause local skin reactions (such as contact dermatitis) or eye and mucous membrane irritation.
Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose is one medicated patch once a day.
Apply a medicated patch to the painful area. The maximum daily dose is 1 medicated patch per day, even if there are multiple injured areas to be treated. Only treat one painful area at a time.
Method of administration
For application to the skin (cutaneous use).
Instructions for use:
To apply the patch:
To remove the patch:
If necessary, the medicated patch can be kept in place using an elastic bandage.
Use the medicated patch only on intact, healthy skin.
Do not use the medicated patch with an airtight (occlusive) dressing.
Do not use it when bathing or showering.
The medicated patch should be used whole. (Do not divide the patch)
Duration of use
Do not use Voltadol for more than 7 days.
If you need to use this medicine for more than 7 days to relieve pain or if the symptoms worsen, you are advised to consult a doctor.
If you use more VOLTADOL than you should
Tell your doctor if you experience significant side effects after incorrect use of this medicine or accidental overdose (e.g., in children). Your doctor may inform you of any measures that need to be taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to use VOLTADOL
Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately and stop using the patch if you notice any of the following side effects:
Sudden itchy rash (hives); swelling of the hands, feet, ankles, face, lips, mouth, or throat; difficulty breathing; low blood pressure or weakness.
You may experience the following side effects:
Common side effects (may affect up to 1 in 10 people):
local skin reactions, such as redness of the skin, burning sensation, itching, inflamed skin redness, rash, sometimes with blisters or hives.
Very rare side effects (may affect up to 1 in 10,000 people):
hypersensitivity reactions or local allergic reactions (contact dermatitis).
In patients using external medicines of the same active substance group as diclofenac, there have been isolated reports of generalized skin rash, hypersensitivity reactions such as skin swelling and mucous membrane irritation, and anaphylactic-type reactions with acute disorders of circulation and light sensitivity reactions.
The absorption of diclofenac into the body through the skin is very low compared to the concentration of the active substance in the blood after oral use of diclofenac. Therefore, the likelihood of systemic side effects (such as gastrointestinal or renal disorders or respiratory difficulties) is very low.
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's website (http://www.aemps.gob.es).
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and pouch after EXP. The expiry date is the last day of the month indicated.
This medicine does not require any special storage temperature. Store in the original package to protect from light and moisture.
Do not use this medicine if you notice it is damaged.
Used medicated patches should be folded in half with the adhesive side inward.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Voltadol
Each medicated patch contains 140 mg of diclofenac in the form of diclofenac sodium.
Outer layer:
Non-woven polyester material
Adhesive layer:
Acrylic dispersion
Tributyl citrate
Butylhydroxyanisole
Protective coating:
Silicone-coated paper
Appearance and packaging of the product
Voltadol is a white medicated adhesive patch, 10 x 14 cm, made of non-woven material on one side and paper on the other. Once the protective film is removed, the adhesive film is translucent and shiny.
Voltadol is available in packs of 2, 5, 7, and 10 medicated patches, each in an individual pouch.
Not all pack sizes may be marketed.
Marketing authorisation holder
Haleon Spain, S.A.
C/ Severo Ochoa, nº 2,
28760, Tres Cantos, Madrid
Spain
Manufacturer
Fidia Farmaceutici S.p.A.
Via Ampère, 29
20037 Paderno Dugnano (MI)
Italy
or
Haleon Germany GmbH
Barthstrasse 4
80339 Munich
Germany
This medicine is authorised in the Member States of the European Economic Area under the following names:
Austria Voltadol 24 Stunden Schmerzpflaster 140 mg wirkstoffhaltiges Pflaster
Belgium Voltaren Patch Once Daily, 140 mg pleister emplâtre médicamenteux / Wirkstoffhaltiges Pflaster.
Bulgaria: ???????? 140 mg ??????? ???????.
Czech Republic: Voltaren 1x denne.
Estonia: Voltinex.
France: Voltarenactigo 140 mg, emplâtre médicamenteux.
Germany: Voltaren 24 Stunden Schmerzpflaster 140 mg wirkstoffhaltiges Pflaster.
Greece: VOLTADOL 24-HOURS
Hungary: Voltaren 140 mg gyógyszeres tapasz
Italy: Voltadol Unidie 140 mg cerotto medicato.
Latvia: Voltinex 140 mg arstnieciskais plaksteris.
Lithuania Voltinex 140 mg vaistinis pleistras.
Luxembourg: Voltaren Patch Once Daily, 140 mg emplâtre médicamenteux / Wirkstoffhaltiges Pflaster.
Netherlands Voltaren Pleister 140 mg.
Poland: Voltaren Forte.
Portugal: Voltaren 24h, 140 mg, emplastro medicamentoso.
Romania: Voltaren 140 mg emplastru medicamentos.
Spain: Voltadol 140 mg apósito adhesivo medicamentoso.
Slovak Republic: Voltaren 1x denne 140 mg liecivá náplast.
Date of last revision of this leaflet:September 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) (http://www.aemps.gob.es)